IEZZI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 231
EU - Europa 117
AS - Asia 115
SA - Sud America 15
AF - Africa 2
Totale 480
Nazione #
US - Stati Uniti d'America 228
SG - Singapore 62
RU - Federazione Russa 35
IE - Irlanda 30
DE - Germania 20
CN - Cina 17
VN - Vietnam 15
BR - Brasile 13
HK - Hong Kong 12
UA - Ucraina 8
FI - Finlandia 6
SE - Svezia 5
BD - Bangladesh 3
GB - Regno Unito 3
JP - Giappone 3
BE - Belgio 2
CO - Colombia 2
CZ - Repubblica Ceca 2
IT - Italia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CA - Canada 1
EG - Egitto 1
ES - Italia 1
FR - Francia 1
HN - Honduras 1
IN - India 1
IQ - Iraq 1
MA - Marocco 1
MX - Messico 1
PL - Polonia 1
Totale 480
Città #
Chandler 32
Singapore 32
Dublin 30
San Jose 28
Jacksonville 24
Dallas 23
Ashburn 14
Hong Kong 12
The Dalles 11
Munich 10
Santa Clara 10
New York 9
Ann Arbor 7
Beijing 7
Ho Chi Minh City 7
Moscow 6
Boardman 4
Bremen 4
Columbus 4
Dearborn 4
Lawrence 4
Los Angeles 4
Orem 4
Princeton 4
Tokyo 3
Turku 3
Wilmington 3
Brno 2
Brooklyn 2
Brussels 2
Council Bluffs 2
Dong Ket 2
Helsinki 2
Seattle 2
Anyang 1
Argenteuil 1
Baghdad 1
Barranquilla 1
Cacoal 1
Cairo 1
Campo Grande 1
Cao Lanh 1
Cardiff 1
Casablanca 1
Charleston 1
Conceição do Coité 1
Concepción 1
Denver 1
Dhaka 1
Falkenstein 1
Francavilla al Mare 1
Frankfurt am Main 1
Guangzhou 1
Haiphong 1
Hangzhou 1
Hanoi 1
Houston 1
Hải Dương 1
Ibiúna 1
João Câmara 1
Lanzhou 1
Lappeenranta 1
Lavras 1
Luís Antônio 1
Manchester 1
Medellín 1
Mexico City 1
Minneapolis 1
Poplar 1
Quận Ninh Kiều 1
Rio de Janeiro 1
Rohtak 1
San Pedro Sula 1
Stockholm 1
São José do Rio Preto 1
São Paulo 1
Taiyuan 1
Tutóia 1
Urbandale 1
Vienna 1
Volta Redonda 1
Warsaw 1
Totale 365
Nome #
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 146
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 118
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 112
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 108
Totale 484
Categoria #
all - tutte 2.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.195


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 5 2
2021/202217 0 1 0 0 5 0 0 4 1 0 1 5
2022/202384 4 8 1 12 8 8 0 4 39 0 0 0
2023/202426 4 1 1 0 1 10 0 0 0 1 1 7
2024/2025110 1 1 6 5 18 6 13 5 30 3 16 6
2025/2026192 14 13 22 20 21 19 29 12 18 24 0 0
Totale 484